Shi Haoyuan, Xu Tao, Li Xiaodi, Gao Qian, Xiong Zhiwei, Xia Junfeng, Yue Zhenyu
University of Science and Technology of China, Hefei, 230026, Anhui, China; School of Information and Artificial Intelligence, Anhui Agricultural University, Hefei, 230036, Anhui, China.
School of Information and Artificial Intelligence, Anhui Agricultural University, Hefei, 230036, Anhui, China.
Artif Intell Med. 2025 May;163:103101. doi: 10.1016/j.artmed.2025.103101. Epub 2025 Mar 4.
Predicting the response of a cancer cell line to a therapeutic drug is pivotal for personalized medicine. Despite numerous deep learning methods that have been developed for drug response prediction, integrating diverse information about biological entities and predicting the directional response remain major challenges. Here, we propose a novel interpretable predictive model, DRExplainer, which leverages a directed graph convolutional network to enhance the prediction in a directed bipartite network framework. DRExplainer constructs a directed bipartite network integrating multi-omics profiles of cell lines, the chemical structure of drugs and known drug response to achieve directed prediction. Then, DRExplainer identifies the most relevant subgraph to each prediction in this directed bipartite network by learning a mask, facilitating critical medical decision-making. Additionally, we introduce a quantifiable method for model interpretability that leverages a ground truth benchmark dataset curated from biological features. In computational experiments, DRExplainer outperforms state-of-the-art predictive methods and another graph-based explanation method under the same experimental setting. Finally, the case studies further validate the interpretability and the effectiveness of DRExplainer in predictive novel drug response. Our code is available at: https://github.com/vshy-dream/DRExplainer.
预测癌细胞系对治疗药物的反应对于个性化医疗至关重要。尽管已经开发了许多用于药物反应预测的深度学习方法,但整合有关生物实体的各种信息并预测定向反应仍然是主要挑战。在此,我们提出了一种新颖的可解释预测模型DRExplainer,它在有向二分网络框架中利用有向图卷积网络来增强预测。DRExplainer构建了一个有向二分网络,整合细胞系的多组学特征、药物的化学结构和已知的药物反应,以实现定向预测。然后,DRExplainer通过学习一个掩码来识别该有向二分网络中与每个预测最相关的子图,促进关键的医疗决策。此外,我们引入了一种基于从生物学特征策划的真实基准数据集的模型可解释性量化方法。在计算实验中,在相同实验设置下,DRExplainer优于现有最先进的预测方法和另一种基于图的解释方法。最后,案例研究进一步验证了DRExplainer在预测新型药物反应方面的可解释性和有效性。我们的代码可在以下网址获取:https://github.com/vshy-dream/DRExplainer。